| 2201 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
15 |
| 2202 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
17 |
| 2203 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
81 |
| 2204 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
29 |
| 2205 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
15 |
| 2206 |
Bone Marrow |
Allogeneic
|
Severe Combined Immunodeficiency
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
1 |
| 2207 |
Bone Marrow |
Allogeneic
|
Sickle Cell Disease
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
5 |
| 2208 |
Bone Marrow |
Allogeneic
|
T-Acute Lymphoblastic Leukemia, Ataxia Telangiectasia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
8 |
| 2209 |
Bone Marrow |
Allogeneic
|
T-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
16 |
| 2210 |
Bone Marrow |
Allogeneic
|
Thalassemia Major
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
2 |
| 2211 |
Bone Marrow |
Allogeneic
|
Very Severe Aplastic Anemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
21 |
| 2212 |
Bone Marrow |
Allogeneic
|
Wiskott-Aldrich Syndrome
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
1 |
| 2213 |
Bone Marrow |
Allogeneic
|
Wiskott-Aldrich Syndrome
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
3 |
| 2214 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
67 |
| 2215 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
37 |
| 2216 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
47 |
| 2217 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
16 |
| 2218 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
58 |
| 2219 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
64 |
| 2220 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
66 |
| 2221 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
11 |
| 2222 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
8 |
| 2223 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
52 |
| 2224 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
51 |
| 2225 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
54 |
| 2226 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
54 |
| 2227 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
40 |
| 2228 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
60 |
| 2229 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
40 |
| 2230 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
51 |
| 2231 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
35 |
| 2232 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
65 |
| 2233 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
47 |
| 2234 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
39 |
| 2235 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
54 |
| 2236 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
37 |
| 2237 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
54 |
| 2238 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
19 |
| 2239 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
20 |
| 2240 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
37 |
| 2241 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
42 |
| 2242 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
48 |
| 2243 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
47 |
| 2244 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
64 |
| 2245 |
Apheresis |
Autologous
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
61 |
| 2246 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
20 |
| 2247 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
65 |
| 2248 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
40 |
| 2249 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
57 |
| 2250 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
44 |
| 2251 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
54 |
| 2252 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
31 |
| 2253 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
30 |
| 2254 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
60 |
| 2255 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia T-Cell; Myelodysplastic Syndrome
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
72 |
| 2256 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
58 |
| 2257 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
60 |
| 2258 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
32 |
| 2259 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
28 |
| 2260 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
50 |
| 2261 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
70 |
| 2262 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
50 |
| 2263 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
64 |
| 2264 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
63 |
| 2265 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
41 |
| 2266 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
57 |
| 2267 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
63 |
| 2268 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
38 |
| 2269 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
57 |
| 2270 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
57 |
| 2271 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
67 |
| 2272 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
87 |
| 2273 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
71 |
| 2274 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
60 |
| 2275 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
47 |
| 2276 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
46 |
| 2277 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
56 |
| 2278 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
46 |
| 2279 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
33 |
| 2280 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
53 |
| 2281 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
55 |
| 2282 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
69 |
| 2283 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
38 |
| 2284 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
57 |
| 2285 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
1 |
| 2286 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
28 |
| 2287 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
55 |
| 2288 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
60 |
| 2289 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
62 |
| 2290 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
60 |
| 2291 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
31 |
| 2292 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
67 |
| 2293 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
73 |
| 2294 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
82 |
| 2295 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
73 |
| 2296 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
55 |
| 2297 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
59 |
| 2298 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
72 |
| 2299 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
55 |
| 2300 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
41 |